Amylin Uncovered: A Review on the Polypeptide Responsible for Type II Diabetes
Open Access
- 31 March 2013
- journal article
- review article
- Published by Hindawi Limited in BioMed Research International
- Vol. 2013, 1-17
- https://doi.org/10.1155/2013/826706
Abstract
Amylin is primarily responsible for classifying type II diabetes as an amyloid (protein misfolding) disease as it has great potential to aggregate into toxic nanoparticles, thereby resulting in loss of pancreatic -cells. Although type II diabetes is on the increase each year, possibly due to bad eating habits of modern society, research on the culprit for this disease is still in its early days. In addition, unlike the culprit for Alzheimers disease, amyloid -peptide, amylin has failed to receive attention worthy of being featured in an abundance of review articles. Thus, the aim of this paper is to shine the spotlight on amylin in an attempt to put it onto the top of researchers to-do list since the secondary complications of type II diabetes have far-reaching and severe consequences on public health both in developing and fully developed countries alike. This paper will cover characteristics of the amylin aggregates, mechanisms of toxicity, and a particular focus on inhibitors of toxicity and techniques used to assess these inhibitors. Amylin is primarily responsible for classifying type II diabetes as an amyloid (protein misfolding) disease as it has great potential to aggregate into toxic nanoparticles, thereby resulting in loss of pancreatic -cells. Although type II diabetes is on the increase each year, possibly due to bad eating habits of modern society, research on the culprit for this disease is still in its early days. In addition, unlike the culprit for Alzheimers disease, amyloid -peptide, amylin has failed to receive attention worthy of being featured in an abundance of review articles. Thus, the aim of this paper is to shine the spotlight on amylin in an attempt to put it onto the top of researchers to-do list since the secondary complications of type II diabetes have far-reaching and severe consequences on public health both in developing and fully developed countries alike. This paper will cover characteristics of the amylin aggregates, mechanisms of toxicity, and a particular focus on inhibitors of toxicity and techniques used to assess these inhibitors.This publication has 130 references indexed in Scilit:
- Identifying and validating biomarkers for Alzheimer's diseaseTrends in Biotechnology, 2011
- Efficient Microwave-Assisted Synthesis of Human Islet Amyloid Polypeptide Designed to Facilitate the Specific Incorporation of Labeled Amino AcidsOrganic Letters, 2010
- The Sulfated Triphenyl Methane Derivative Acid Fuchsin Is a Potent Inhibitor of Amyloid Formation by Human Islet Amyloid Polypeptide and Protects against the Toxic Effects of Amyloid FormationJournal of Molecular Biology, 2010
- Polymorphism in Alzheimer Aβ Amyloid Organization Reflects Conformational Selection in a Rugged Energy LandscapeChemical Reviews, 2010
- Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer’s and Parkinson’s diseasesApoptosis, 2010
- Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosisDiabetologia, 2009
- Amylin Proprotein Processing Generates Progressively More Amyloidogenic Peptides that Initially Sample the Helical StateBiochemistry, 2008
- Peptide Conformation and Supramolecular Organization in Amylin Fibrils: Constraints from Solid-State NMRBiochemistry, 2007
- Structure of the cross-β spine of amyloid-like fibrilsNature, 2005
- Protein folding and misfoldingNature, 2003